These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10526007)

  • 1. Immunohistochemical demonstration of oncocytes in nongonadotrophic pituitary adenomas.
    Nishioka H; Ito H; Hirano A
    Virchows Arch; 1999 Oct; 435(4):428-33. PubMed ID: 10526007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical study of pituitary oncocytic adenomas.
    Nishioka H; Ito H; Hirano A; Shibata N; Kobayashi M
    Acta Neuropathol; 1997 Jul; 94(1):42-7. PubMed ID: 9224529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cavernous sinus invasion and tumor proliferative potential of growth hormone-producing pituitary tumors.
    Iuchi S; Saeki N; Uchino Y; Higuchi Y; Tatsuno I; Nakamura S; Yasuda T; Yamaura A
    Endocr J; 2000 Mar; 47 Suppl():S77-9. PubMed ID: 10890190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary hormone mRNA in null cell adenomas and oncocytomas by in situ hybridization comparison with immunohistochemical and clinical data.
    Schmid M; Münscher A; Saeger W; Schreiber S; Lüdecke DK
    Pathol Res Pract; 2001; 197(10):663-9. PubMed ID: 11700887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analyses of oncocytic and chromophobe pituitary adenomas.
    Günzl HJ; Saeger W; Diehl S; Lüdecke DK
    Exp Clin Endocrinol; 1988 Sep; 92(1):51-8. PubMed ID: 2465910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of neuroendocrine secretory protein-55 (NESP-55) in pituitary adenomas.
    Gupta M; Lloyd RV; Fischer-Colbrie R; Tischler AS; Dayal Y
    Endocr Pathol; 2011 Sep; 22(3):150-4. PubMed ID: 21584660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between cell proliferation activity and secretory activity in pituitary adenoma--a review of 63 cases].
    Asano K; Kubo O; Tajika Y; Huang MC; Takakura K
    No To Shinkei; 1996 Jun; 48(6):543-9. PubMed ID: 8703557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocytic transformation in pituitary adenomas: immunohistochemical analyses of 65 cases.
    Niveiro M; Aranda FI; Payá A; Boix E; Peiró G; Picó A
    Arch Pathol Lab Med; 2004 Jul; 128(7):776-80. PubMed ID: 15214824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation markers in different types of clinically non-secreting pituitary adenomas.
    Schreiber S; Saeger W; Lüdecke DK
    Pituitary; 1999 May; 1(3-4):213-20. PubMed ID: 11081200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.
    Vidal S; Kovacs K; Horvath E; Rotondo F; Kuroki T; Lloyd RV; Scheithauer BW
    Mod Pathol; 2002 Nov; 15(11):1205-12. PubMed ID: 12429800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.
    Miyakoshi T; Takei M; Kajiya H; Egashira N; Takekoshi S; Teramoto A; Osamura RY
    Endocr Pathol; 2008; 19(4):261-73. PubMed ID: 19034702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation, vascular endothelial growth factor expression and cavernous sinus invasion in growth hormone secreting pituitary adenomas.
    Iuchi T; Saeki N; Osato K; Yamaura A
    Acta Neurochir (Wien); 2000; 142(12):1345-51. PubMed ID: 11214627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology.
    Yamada S; Aiba T; Sano T; Kovacs K; Shishiba Y; Sawano S; Takada K
    Neurosurgery; 1993 Jul; 33(1):20-7. PubMed ID: 7689191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor in pituitary adenomas of the gonadotroph cell complex.
    Saeger W; Schreiber S; Lüdecke DK
    Pathol Res Pract; 2000; 196(11):771-3. PubMed ID: 11186173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical demonstration of tenascin in human pituitary glands and adenomas.
    Ikeda H; Yoshimoto T; Fujiwara K; Ogawa Y
    Acta Histochem; 1995 Jul; 97(3):273-80. PubMed ID: 8525784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasiveness.
    Qian ZR; Sano T; Asa SL; Yamada S; Horiguchi H; Tashiro T; Li CC; Hirokawa M; Kovacs K; Ezzat S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1904-11. PubMed ID: 15070963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison.
    Yamada S; Asa SL; Kovacs K
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(4):333-9. PubMed ID: 3140478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.